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Introduction
Hydrops fetalis (HF) is defined as the excessive accumulation 
of fluid in two or more  interstitial compartment of the 
fetus. The presentations are ascites, scalp edema, pleural 
effusions, pericardial effusions leading to anasarca and 
polyhydramnios [1]. These clinical findings with the 
absence of maternal-fetal blood incompatibility define non 
immune hydrops fetalis (NIHF). The widespread use of 
Rh(D) immnunoglobulin has dramatically decreased the 
prevalence of Rh isoimmunisation and NIHF accounts for 
almost 90% of hydrops cases currently [2].
The incidence of NIHF varies from 1 in 830 to 1 in 3500 
deliveries [3]. About 10 to 20% of cases are idiopathic. 
The most common conditions associated with NIHF are 
congenital heart defects and rhythm abnormalities (19-25%), 
chromosomal disorders (35%), infections (1-8%) and some 
other syndromes (9%) [3]. The commonest chromosomal 
anomaly is Turner syndrome. Genetic syndromes such as 
achondrogenesis types 1B, and 2, arthrogryposis multiplex 
congenita, Cornelia de Lange, myotonic dystrophy,  Noonan 
syndrome (NS), Prune belly, tuberous sclerosis, and inborn 
errors of metabolism such as glycogen storage disease type 4, 
lysosomal storage diseases, carnitine deficiency, and thyroid 
disease have all been described as associated with NIHF [1]. 
This article includes two hydropic premature infants with 
favorable outcome. 
Case Reports
Case 1
The mother, a 28 year-old primigravida, noticed the 
sudden cessation of fetal movements at the 31st week of 
an uneventful pregnancy. Ultrasonographic examination 
confirmed the diagnosis of fetal tachycardia and hydrops 
fetalis. The hydropic male infant was delivered by an 
emergency cesarean section. The birth weight was 2300 g, 
and the apgar scores were 1/4/5 at 1, 5 and 10 min respectively. 
He was resuscitated and surfactant was administered in the 
delivery room. Generalised massive skin and scalp edema 
and ascites were present on physical examination. He needed 
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Non immune hydrops fetalis is defined as the excessive accumulation 
of fluid in two or more compartments of the fetus in the absence of 
any maternal-fetal blood incompatibility. The clinical presentations 
include ascites, scalp edema, pleural or pericardial effusions 
and polyhydramnios.  Perinatal mortality in this severe clinical 
condition is high, between 50-98%. Prematurity is an important risk 
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and ventilation management during the last decade in neonatal 
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for hydropic infants. This is the report of the management of two 
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infants had a good prognosis.
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ÖZET
Non immun hidrops fetalis anne ve bebek arasında kan uyuşmazlığı 
olmaksızın fetüsde iki veya daha fazla vücut boşluğunda fazla sıvı 
birikmesi olarak tanımlanır. Asit, saçlı deride ödem, plevral ve 
perikardiyal efüzyon ve polihidramnios klinik tabloyu oluşturur. Bu 
ağır klinik tabloda perinatal mortalite %50-98 arasında yüksektir. 
Prematüre doğum mortalite için önemli bir risk faktörüdür. 
Yenidoğan yoğun bakım ünitelerinde son on yılda tanı, tedavi 
ve ventilasyon uygulamalarındaki gelişmelere rağmen, hidropik 
bebeklerde mortalite oranları fazla değişmemiştir. Bu yazıda 
hidropik doğan iki prematüre bebeğin takibi sunulmuştur. Birinci 
olguda fetal taşiaritmiye, ikinci olguda Noonan sendromuna bağlı 
non immun hidrops fetalis gelişmiştir.  İki vakada da prognoz iyi 
olmuştur.
Anahtar kelimeler: Non immun hidrops fetalis, Fetal taşiaritmi, 
Noonan sendromu
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high pressure ventilation with a peak inspiratory pressure of 
34 cmH2O and a positive end expiratory pressure of 7 cmH2O 
and FiO2 100% during the first hours of life. Massive ascites 
and a minimal pleural effusion were detected by ultrasound. 
Edema was treated with 10% human albumine infusion (1gr/
kg during two hours) followed by furosemide (1 mg/kg/
dose IV) and paracentesis was performed. After the second 
dose of surfactant therapy at the third hour of extrauterine 
life the ventilation parameters were decreased gradually. 
Cranial ultrasonography revealed hyperechogenic areas 
due to edema. Electrocardiograpy (ECG) showed a Wolff-
Parkinson-White (WPW) pattern while echocardiography 
(ECHO) was normal. Mechanical ventilation was needed  for 
two days and the patient’s weight dropped to 1890 g on the 
third day.
The patient had recurrent paroxysms of tachycardia (300/
min), with good response to adenosine on his fifth day of life. 
Consequently the patient was treated with oral digoxine (6 
µg/kg/day) and propranolol (2 mg/kg/day).  Further recovery 
was uneventful and he was discharged on day 21. 
Since tachyarrhythmia did not repeat, the medication 
was discontinued at one-year of age. The neuro-motor 
development was normal at two year of age. 
Case 2 
A small pleural effusion and nuchal thickness in the 
fetus was detected at the routine examination of a 42 year 
old gravida 2, para 1 mother at the 18th  week’ of gestation. 
Pleural effusion was resolved spontaneously in a month. 
Amniocentesis was performed because of the increased fetal 
nuchal thickness and revealed a normal karyotype. However 
a mutation in the PTPN11 gene was found. The fetal ECHO 
was normal. Pleural effusion bilaterally was detected at 31+3 
gestational weeks and progressed to hydrops fetalis during 
48 hours. The mother was referred to our hospital for the 
delivery of this high risk baby. The delivery was performed 
by C/S and the apgar scores were 5/7/8 at 1, 5 and 10 min 
respectively. Birth weight was 2500 g. The baby had ascites 
and severe generalized edema. She was intubated in the 
delivery room, given surfactant and bilateral thorax drainage 
was performed just after the delivery. 
The total thorax drainage was 340 ml during the first 
hour after delivery and microscopic investigation revealed 
90% lymphocytes with sterile culture, which is compatible 
with chylothorax. Structural anomalies of the heart were 
ruled out by ECHO at the first day of extrauterine life. 
The weight dropped to 1850 g on the third day. Since the 
chylothorax persisted (120 ml/day) despite total parenteral 
nutrition and minimal enteral feeding with a medium chain 
triglyceride (MCT) formula, intravenous octreotide infusion 
was started (5µg/kg/h) on day 7. The chylothorax was then 
managed successfully. There were no side effects related to 
the octreotide therapy. The baby was extubated on day 11. 
A second ECHO performed because of a murmur on day 15 
revealed pulmonary valve stenosis. Total parenteral nutrition 
was stopped on day 19 and the MCT formula was transitioned 
to breast milk on day 30. Hypertelorism and epicanthic folds 
were prominent when the baby was 1 month old. She was 
discharged home at 39th day of  life.
The PTPN11 mutation is commonly found in NS. The 
pulmonary stenosis, hypertelorism and epicanthic folds 
in this baby are clinical features of NS.  The first ECHO 
performed after delivery was normal as cardiac anomalies 
in NS are late-onset progressive pathologies. The second 
echocardiographic examination was performed because of 
a newly heard murmur and revealed mild pulmonary valve 
stenosis. Any intervention for the the pulmonary stenosis was 
not needed in the first year of life. The neurodevelopmental 
assessment at one year of age was normal.
Discussion
Non-immune hydrops fetalis presenting before 24 weeks 
is usually due to chromosomal aberrations, while hydrops 
presenting after 24 weeks’s gestation is usually due to 
structural anomalies [2]. In accordance with this, first fetus 
with the WPW syndrome developed hydrops after 30th 
week’s of gestation. However, the pleural effusion was 
detected at the 18th  week of gestation in the second fetus 
with the PTPN11 mutation. Lymphatic vessel dysplasia, 
hypoplasia, or aplasia are common findings in NS (20%)  and 
this disorder of lymphatic development may cause peripheral 
lymphedema, chylothorax, and NIHF [4]. Thus pleural 
effusion may be the early presentation of NIHF.
Heart rhythm disorders are a common cause of NIHF. 
The incidence of NIHF in fetal supraventricular tachycardia 
is between 35-60% [5,6]. The physiologic volume overload 
of the fetal right heart and the reduced compliance of the 
fetal ventricular myocardium increases the risk of the fetus 
developing systemic edema. Impaired protein synthesis 
due to passive congestion of the liver may precipitate rapid 
development of  fetal NIHF [5].  The treatment of fetal 
arrhythmias is possible by administration of medications to 
the mother. Digoxin is the first-choice drug for the treatment 
of in utero fetal tachyarrhytmias. In the event of sustained 
fetal tachycardia despite  maternal administration of digoxin, 
β blocking agents are the second agent generally used and 
flecainide can be considered as a third-line therapy [5,6]. 
Close monitoring of the mother’s heart is essential when 
medication is done. 
Because of the low umbilical cord blood flow in Doppler 
ultrasound, medical management was not possible in the first 
case with in utero fetal tacharrhythmia and delivery was done 
by emergency c/s. However, the hydropic fetus and placenta 
tend to absorb maternally administered antiarrhythmic agents 
less well than the nonhydropic fetuses [5].
Needle aspiration of pleural effusions, feto-amniotic 
shunting and amnioreduction are usual antenatal surgical 
interventions in hydrops fetalis. These interventions are 
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associated with a high risk of preterm premature rupture of 
membranes or chorioamnionitis and may provoke preterm 
labor. Thoracentesis before delivery may facilitate neonatal 
resuscitation in some cases [7].
There are no evidence-based guidelines about the 
best time and mode of delivery for hydropic babies. Since 
prematurity is an important risk factor for mortality in NIHF, 
delivering fetuses early to treat worsening hydrops may not 
improve survival rates. However intrauterine death is another 
risk. Delivery is recommended if fetal testing becomes non-
reassuring, if pre-eclampsia complicates the hydrops or 
preterm labour is established. Cesarean section has not been 
shown to improve neonatal outcome, but it does allow for a 
planned resuscitation by the neonatal team and may avoid the 
problem of soft tissue dystocia [7]. 
Hydrops fetalis may result in intrauterine or early 
postnatal death, sometimes even in the delivery room [1]. 
Both infants were born by C/S and the neonatal intensive 
care team were informed about the condition and history of 
the babies before delivery in detail. Two doctors experienced 
in preterm resuscitation were ready in the delivery room 
in both cases. For the second infant, since the obstetrician 
emphasized the bilaterally massive pleural effusion, a 
pediatric surgeon was also ready in the delivery room. 
While one was intubating the baby other doctors performed 
thoracentesis bilaterally which enabled ventilation in this 
case. Early surfactant replacement was needed in both cases 
in order to achive ventilation. Mechanical ventilation with 
high peak inspiratory pressure (38 gradually decreased to 30 
cmH2O) during the first hour of life was also needed. Hydrops 
fetalis is a very severe condition and hydropic babies may 
need prompt interventions such as intubation and surfactant 
replacement, umbilical catheterization,  thoracentesis or 
paracentesis in the delivery room. It is important for these 
deliveries to be done in tertiary-care centers where adequate 
equipment and an experienced team are available. 
The neurodevelopmental outcome of hydropic infants is 
of concern. The underlying cause of NIHF effects the long-
term survival rates. However, 68-90% of survivors have a 
normal development [8,9]. No neurodevelopmental delay 
was seen in either infant.
Non immune hydrops fetalis is associated with an overall 
perinatal mortality rate of 50-98% [10,11]. Mortality rates 
differ according to the presence of prematurity, chromosomal 
abnormalities, associated lethal malformations and 
pulmonary hypoplasia produced by fetal pleural effusions   in 
NIHF.  Unexplained cases may have the poorest outcome [1]. 
Despite many advances in diagnosis and therapy in NICU, 
the mortality rate has not changed very much over the past 
15 years [1,9].
In conclusion, neonatal management of NIHF requires a 
skilled and coordinated resuscitation team supported by a well 
equipped neonatal intensive care unit. Preterm infants with 
NIHF can have good prognosis if structural heart anomalies, 
chromosomal abnormalities and lethal malformations do not 
complicate the NIHF.
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